By Nancy Walsh, Staff Writer, MedPage Today
Published: April 08, 2013
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner
The risk of cancer was increased in men taking the antiarrhythmia drug amiodarone, particularly in those with extensive exposure to the drug, a retrospective study found.
Among men taking amiodarone, the risk for any cancer rose by almost 20% compared with the general population, with a standardized incidence ratio of 1.18 (95% CI 1.02 to 1.36, P=0.022), according to Chia-Jen Liu, MD, of National Yang-Ming University Hospital in Yilan, Taiwan, and colleagues.